Notice2026-01109
Proposed Collection; 60-Day Comment Request; The Genetic Testing Registry (Office of the Director)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 22, 2026
Effective
March 23, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institutes of Health Office of the Director (OD) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 14 (Thursday, January 22, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 14 (Thursday, January 22, 2026)]
[Notices]
[Page 2788]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-01109]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; The Genetic Testing
Registry (Office of the Director)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide opportunity for public comment on proposed data
collection projects, the National Institutes of Health Office of the
Director (OD) will publish periodic summaries of proposed projects to
be submitted to the Office of Management and Budget (OMB) for review
and approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received by March 23, 2026.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Mr. Taunton
Paine, Director, Division of Scientific Data Sharing Policy, Office of
Science Policy, NIH, (301) 496-9838, <a href="/cdn-cgi/l/email-protection#e1b28288848f8284b18e8d888298a18c80888dcf8f8889cf868e97"><span class="__cf_email__" data-cfemail="7b2818121e15181e2b14171218023b161a121755151213551c140d">[email protected]</span></a>, 6705
Rockledge Dr., Suite 631, Bethesda, MD 20892. Formal requests for
additional plans and instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimizes the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: The Genetic Testing Registry, 0925-0651,
Reinstatement without change, National Institutes of Health Office of
the Director (OD), National Institutes of Health (NIH).
Need and Use of Information Collection: Clinical laboratory tests
are available for more than 26,000 genetic conditions. The Genetic
Testing Registry (GTR) provides a centralized, online location for test
developers, manufacturers, and researchers to voluntarily submit
detailed information about the availability and scientific basis of
their genetic tests. The GTR is of value to clinicians by providing
information about the accuracy, validity, and usefulness of genetic
tests. The GTR also highlights evidence gaps where additional research
is needed. The GTR also has tests for microbes such as SARS-CoV-2 to
diagnose COVID-19.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2837.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average Total
Number of Number of time per annual
Type of respondent Form name respondents responses per response burden
respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Laboratory Personnel Using Bulk Minimal Fields....... 11 16 18/60 53
Submission.
Optional Fields...... 250 16 17/60 1,133
Laboratory Personnel Not Using Bulk Minimal Fields....... 84 16 54/60 1,210
Submission.
Optional Fields...... 57 16 29/60 441
-----------------------------------------------------
Total.......................... ..................... 402 6,432 ........... 2,837
----------------------------------------------------------------------------------------------------------------
Dated: January 14, 2026.
Matthew J. Memoli,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2026-01109 Filed 1-21-26; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 22, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.